Atishay Pharma Private Limited
About Atishay Pharma Private Limited
Data last updated:
Atishay Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U52190MP2020PTC051239. Its GSTIN is 23AATCA4229K1ZF (Madhya Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Jitendra Kumar Jain and Arpit Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 117/4 Anil Nagar, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.74 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.07 Cr (net margin 15.9%) and EBITDA of ₹1.51 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address117/4 Anil Nagar, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Atishay Pharma Private Limited
The main business activity of Atishay Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Atishay Pharma Private Limited FY 2025 filings available
Atishay Pharma Private Limited reported revenue of ₹6.74 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Atishay Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years, including 2% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Atishay Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.51 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Atishay Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 15.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Atishay Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Atishay Pharma Private Limited
Atishay Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chandravim Exim Private Limited | ₹6.81 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | Mumbai, Maharashtra, India |
| NXS Services Private Limited | ₹6.8 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Candaur Pharmaceuticals Private Limited | ₹6.79 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Thane, Maharashtra, India |
| Newtrimed Healthcare Private Limited | ₹6.79 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Elixir Bio Genics Private Limited | ₹6.74 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Chennai, Tamil Nadu, India |
| Atishay Pharma Private Limited this company | ₹6.74 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Sidhi Vinayak Pharma Private Limited | ₹6.74 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Florid Laboratories Private Limited | ₹6.73 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Patna, Bihar, India |
| Domagk Smith Laboratories Private Limited | ₹6.73 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Merz India Healthcare Private Limited | ₹6.73 Cr (FY 2021) | •••• | •••• | -63.0% | •••• | Dadar East, Maharashtra, India |
| Prime Life Science Private Limited | ₹6.72 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Haryana, India |
Peers are the five companies nearest above and the five nearest below Atishay Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Atishay Pharma Private Limited
Atishay Pharma Private Limited is audited by MAHESHWARI & GUPTA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAHESHWARI & GUPTA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Atishay Pharma Private Limited
Atishay Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar Jain Also directs: Vardhman Surrogift Private Limited | Director | 03 Apr 2020 | 6 Years 6 Months | Current |
| Arpit Jain | Additional Director | 20 Jul 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Atishay Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Atishay Pharma Private Limited
Atishay Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Atishay Pharma Private Limited
Employment history and EPFO contributions of people linked to Atishay Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Atishay Pharma Private Limited
Atishay Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Arpit Jain was appointed as Additional Director on 20 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Atishay Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Atishay Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Atishay Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Atishay Pharma Private Limited
Atishay Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AATCA4229K1ZF | Madhya Pradesh | Active | 02 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Atishay Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atishay Pharma Private Limited
Atishay Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 April 2020 (6+ years old) and is registered under CIN U52190MP2020PTC051239.
Atishay Pharma reported revenue of ₹6.74 Cr for FY 2025 (up 2% YoY).
Atishay Pharma has 2 current directors:
- Jitendra Kumar Jain - Director
- Arpit Jain - Additional Director
Atishay Pharma reported a net profit of ₹1.07 Cr (net margin 15.9%) and EBITDA of ₹1.51 Cr (EBITDA margin 22.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Atishay Pharma is 10% over three years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Atishay Pharma is 23AATCA4229K1ZF, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Atishay Pharma is U52190MP2020PTC051239. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atishay Pharma was incorporated on 03 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Atishay Pharma by revenue are Chandravim Exim Private Limited, NXS Services Private Limited, Candaur Pharmaceuticals Private Limited, Newtrimed Healthcare Private Limited, Elixir Bio Genics Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Arpit Jain was appointed as Additional Director on 20 Jul 2024. Chanchal Jain ceased to be Director on 20 Jul 2024. Jitendra Kumar Jain was appointed as Director on 03 Apr 2020.
The registered office of Atishay Pharma is at 1174 Anil Nagar, Indore, Madhya Pradesh, India – 452010.